HBsAg-话题@MedSci

#HBsAg#

29篇内容 | 3584人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2254787, encodeId=0d302254e8721, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=HBsAg清除≠肝癌免疫？庄辉院士深度解析背后原因, objectType=article, longId=865682, objectId=bfac8656821a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250122/1737543636981_8538692.jpg, objectUrl=/article/show_article.do?id=bfac8656821a, replyNumber=0, likeNumber=32, createdTime=2025-03-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=bfac8656821a, moduleTitle=HBsAg清除≠肝癌免疫？庄辉院士深度解析背后原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfac8656821a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2256082, encodeId=80662256082ee, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】“绿洲”项目成果：聚乙二醇干扰素α-2b治疗48周的HBsAg清除预测模型, objectType=article, longId=866442, objectId=066886644286, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=066886644286, replyNumber=0, likeNumber=20, createdTime=2025-03-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=066886644286, moduleTitle=【期刊导读】“绿洲”项目成果：聚乙二醇干扰素α-2b治疗48周的HBsAg清除预测模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=066886644286)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2255821, encodeId=a37c2255821e5, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】再添新证：巩固治疗> 12周、停药时HBsAb阳性可增加HBsAg清除的持久性, objectType=article, longId=866025, objectId=2b56866025ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241107/1730967184313_8538692.jpg, objectUrl=/article/show_article.do?id=2b56866025ce, replyNumber=0, likeNumber=21, createdTime=2025-03-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=2b56866025ce, moduleTitle=【期刊导读】再添新证：巩固治疗> 12周、停药时HBsAb阳性可增加HBsAg清除的持久性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b56866025ce)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2254598, encodeId=c2b02254598d7, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】长期核苷治疗获HBsAg清除仍发生肝癌的慢乙肝患者术后采用PEG IFNα联合治疗有效改善预后, objectType=article, longId=865060, objectId=984b865060ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241127/1732690218078_8538692.jpg, objectUrl=/article/show_article.do?id=984b865060ad, replyNumber=0, likeNumber=22, createdTime=2025-03-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=984b865060ad, moduleTitle=【愈见乙肝2024】长期核苷治疗获HBsAg清除仍发生肝癌的慢乙肝患者术后采用PEG IFNα联合治疗有效改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=984b865060ad)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2253291, encodeId=ad5122532913f, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=018880e834b' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α-2b#</a>, objectTitle=【期刊导读】疗程预测模型：基线HBsAg水平可预测聚乙二醇干扰素α-2b的治疗获得HBsAg清除所需疗程, objectType=article, longId=864489, objectId=2f1e86448947, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250212/1739348837577_8538692.png, objectUrl=/article/show_article.do?id=2f1e86448947, replyNumber=0, likeNumber=17, createdTime=2025-02-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=2f1e86448947, moduleTitle=【期刊导读】疗程预测模型：基线HBsAg水平可预测聚乙二醇干扰素α-2b的治疗获得HBsAg清除所需疗程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f1e86448947)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2248654, encodeId=23002248654b9, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】HBsAg清除、HBsAb水平较低时停药发生HBsAg复阳，短期再治疗获HBsAg血清学转换且HBsAb高, objectType=article, longId=859069, objectId=64ce859069ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=64ce859069ad, replyNumber=0, likeNumber=22, createdTime=2025-01-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=64ce859069ad, moduleTitle=【愈见乙肝2024】HBsAg清除、HBsAb水平较低时停药发生HBsAg复阳，短期再治疗获HBsAg血清学转换且HBsAb高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ce859069ad)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247444, encodeId=aa34224e444ff, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】HBsAg高水平的核苷经治慢乙肝患者经间歇治疗策略获持久的HBsAg血清学转换, objectType=article, longId=857950, objectId=252c85e950a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401030/1730265935847_8538692.jpg, objectUrl=/article/show_article.do?id=252c85e950a3, replyNumber=0, likeNumber=32, createdTime=2025-01-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=252c85e950a3, moduleTitle=【愈见乙肝2024】HBsAg高水平的核苷经治慢乙肝患者经间歇治疗策略获持久的HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=252c85e950a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247315, encodeId=67a5224e315e7, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】党双锁教授团队：巩固治疗< 12周和HBsAb消失是HBsAg清除后复发的高危因素, objectType=article, longId=857798, objectId=f80b85e79864, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240723/1721699880262_92910.jpg, objectUrl=/article/show_article.do?id=f80b85e79864, replyNumber=0, likeNumber=34, createdTime=2025-01-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f80b85e79864, moduleTitle=【期刊导读】党双锁教授团队：巩固治疗< 12周和HBsAb消失是HBsAg清除后复发的高危因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f80b85e79864)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2244047, encodeId=02d8224404e8b, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】HBsAg清除后复阳的慢乙肝患者经联合抗病毒治疗短期内获临床治愈, objectType=article, longId=856210, objectId=e67d8562102a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=e67d8562102a, replyNumber=0, likeNumber=36, createdTime=2024-12-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=e67d8562102a, moduleTitle=【愈见乙肝2024】HBsAg清除后复阳的慢乙肝患者经联合抗病毒治疗短期内获临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e67d8562102a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243638, encodeId=1fdd22436387c, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【AASLD2024速递】50岁前获得HBsAg清除的无肝硬化慢乙肝患者预后更好, objectType=article, longId=856068, objectId=ebb3856068d6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240514/1715679836336_5579292.jpg, objectUrl=/article/show_article.do?id=ebb3856068d6, replyNumber=0, likeNumber=37, createdTime=2024-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=ebb3856068d6, moduleTitle=【AASLD2024速递】50岁前获得HBsAg清除的无肝硬化慢乙肝患者预后更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebb3856068d6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2237343, encodeId=09e0223e343be, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】RCT研究：非活动性HBsAg携带状态人群基于聚乙二醇干扰素α治疗48周的HBsAg清除率近40%, objectType=article, longId=850137, objectId=537285013e3b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=537285013e3b, replyNumber=0, likeNumber=55, createdTime=2024-11-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=537285013e3b, moduleTitle=【AASLD2024速递】RCT研究：非活动性HBsAg携带状态人群基于聚乙二醇干扰素α治疗48周的HBsAg清除率近40%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=537285013e3b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2236579, encodeId=3ea022365e917, content=<a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=陈新月教授：非活动性HBsAg携带人群的诊疗进展, objectType=article, longId=849662, objectId=e3f88496629a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719481658993_92910.png, objectUrl=/article/show_article.do?id=e3f88496629a, replyNumber=0, likeNumber=49, createdTime=2024-11-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e3f88496629a, moduleTitle=陈新月教授：非活动性HBsAg携带人群的诊疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3f88496629a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2234368, encodeId=da07223436876, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】Treg细胞可预测PegIFNα-2b治疗的HBsAg清除, objectType=article, longId=849225, objectId=290484922582, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240623/1719152329615_5579292.png, objectUrl=/article/show_article.do?id=290484922582, replyNumber=0, likeNumber=51, createdTime=2024-10-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=290484922582, moduleTitle=【AASLD2024速递】Treg细胞可预测PegIFNα-2b治疗的HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=290484922582)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2233438, encodeId=cbca2233438db, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】提高HBsAg清除持久性的策略研究, objectType=article, longId=848852, objectId=feef8488524d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401026/1729954243486_8538692.png, objectUrl=/article/show_article.do?id=feef8488524d, replyNumber=0, likeNumber=50, createdTime=2024-10-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=feef8488524d, moduleTitle=【AASLD2024速递】提高HBsAg清除持久性的策略研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feef8488524d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231744, encodeId=f3272231e44af, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=018880e834b' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α-2b#</a>, objectTitle=【AASLD2024速递】聚乙二醇干扰素α-2b治疗获得HBsAg清除的疗程预测：基于基线HBsAg水平建立的简单模型, objectType=article, longId=847767, objectId=0eab84e7678f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=0eab84e7678f, replyNumber=0, likeNumber=65, createdTime=2024-10-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0eab84e7678f, moduleTitle=【AASLD2024速递】聚乙二醇干扰素α-2b治疗获得HBsAg清除的疗程预测：基于基线HBsAg水平建立的简单模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eab84e7678f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231347, encodeId=5470223134e2e, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】预测获得HBsAg清除的慢乙肝患者肝脏相关不良结局风险的机器学习新模型, objectType=article, longId=845307, objectId=424484530edd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240607/1717775297944_5579292.jpg, objectUrl=/article/show_article.do?id=424484530edd, replyNumber=0, likeNumber=89, createdTime=2024-10-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=424484530edd, moduleTitle=【期刊导读】预测获得HBsAg清除的慢乙肝患者肝脏相关不良结局风险的机器学习新模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=424484530edd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2229999, encodeId=5f9022299994a, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=998699e63f' target=_blank style='color:#2F92EE;'>#IP-10#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=b6cd1199e3e6' target=_blank style='color:#2F92EE;'>#PegIFN-α#</a>, objectTitle=【期刊导读】慢乙肝患者治疗早期血清IP-10水平与HBsAg应答情况相关, objectType=article, longId=844209, objectId=4dc08442096d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719489899523_2570354.png, objectUrl=/article/show_article.do?id=4dc08442096d, replyNumber=0, likeNumber=120, createdTime=2024-10-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4dc08442096d, moduleTitle=【期刊导读】慢乙肝患者治疗早期血清IP-10水平与HBsAg应答情况相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dc08442096d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228076, encodeId=25d622280e6fd, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=cb65813029a' target=_blank style='color:#2F92EE;'>#肝硬化#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【期刊导读】系统综述：慢性HBV感染者的HBsAg水平与肝硬化和肝癌风险显著相关, objectType=article, longId=843584, objectId=b28f843584de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=b28f843584de, replyNumber=0, likeNumber=137, createdTime=2024-09-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b28f843584de, moduleTitle=【期刊导读】系统综述：慢性HBV感染者的HBsAg水平与肝硬化和肝癌风险显著相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b28f843584de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227827, encodeId=a9e6222e827d3, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=5fcb113801f8' target=_blank style='color:#2F92EE;'>#HBsAb#</a>, objectTitle=【临床治愈集结号】HBsAg和HBsAb双阳性的不确定期慢乙肝患者经延长治疗终获临床治愈, objectType=article, longId=843317, objectId=4e3484331ee0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=4e3484331ee0, replyNumber=0, likeNumber=72, createdTime=2024-09-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4e3484331ee0, moduleTitle=【临床治愈集结号】HBsAg和HBsAb双阳性的不确定期慢乙肝患者经延长治疗终获临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e3484331ee0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225073, encodeId=0e3922250e377, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换, objectType=article, longId=841868, objectId=e85284186840, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=e85284186840, replyNumber=0, likeNumber=82, createdTime=2024-09-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e85284186840, moduleTitle=【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e85284186840)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

HBsAg

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢性乙型肝炎#

HBsAg清除≠肝癌免疫？庄辉院士深度解析背后原因

2025-03-05发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】“绿洲”项目成果：聚乙二醇干扰素α-2b治疗48周的HBsAg清除预测模型

2025-03-14发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】再添新证：巩固治疗> 12周、停药时HBsAb阳性可增加HBsAg清除的持久性

2025-03-13发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】长期核苷治疗获HBsAg清除仍发生肝癌的慢乙肝患者术后采用PEG IFNα联合治疗有效改善预后

2025-03-04发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α-2b#

【期刊导读】疗程预测模型：基线HBsAg水平可预测聚乙二醇干扰素α-2b的治疗获得HBsAg清除所需疗程

2025-02-24发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】HBsAg清除、HBsAb水平较低时停药发生HBsAg复阳，短期再治疗获HBsAg血清学转换且HBsAb高

2025-01-18发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】HBsAg高水平的核苷经治慢乙肝患者经间歇治疗策略获持久的HBsAg血清学转换

2025-01-10发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】党双锁教授团队：巩固治疗< 12周和HBsAb消失是HBsAg清除后复发的高危因素

2025-01-09发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】HBsAg清除后复阳的慢乙肝患者经联合抗病毒治疗短期内获临床治愈

2024-12-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【AASLD2024速递】50岁前获得HBsAg清除的无肝硬化慢乙肝患者预后更好

2024-12-19发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #AASLD2024#

【AASLD2024速递】RCT研究：非活动性HBsAg携带状态人群基于聚乙二醇干扰素α治疗48周的HBsAg清除率近40%

2024-11-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#乙肝# #HBsAg#

陈新月教授：非活动性HBsAg携带人群的诊疗进展

2024-11-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #Treg细胞# #AASLD2024#

【AASLD2024速递】Treg细胞可预测PegIFNα-2b治疗的HBsAg清除

2024-10-31发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #AASLD 2024#

【AASLD2024速递】提高HBsAg清除持久性的策略研究

2024-10-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #聚乙二醇干扰素α-2b#

【AASLD2024速递】聚乙二醇干扰素α-2b治疗获得HBsAg清除的疗程预测：基于基线HBsAg水平建立的简单模型

2024-10-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】预测获得HBsAg清除的慢乙肝患者肝脏相关不良结局风险的机器学习新模型

2024-10-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #IP-10# #慢乙肝# #PegIFN-α#

【期刊导读】慢乙肝患者治疗早期血清IP-10水平与HBsAg应答情况相关

2024-10-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #肝硬化# #HBsAg# #HBV#

【期刊导读】系统综述：慢性HBV感染者的HBsAg水平与肝硬化和肝癌风险显著相关

2024-09-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #HBsAb#

【临床治愈集结号】HBsAg和HBsAb双阳性的不确定期慢乙肝患者经延长治疗终获临床治愈

2024-09-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换

2024-09-10发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务